Bipolar disorder: Microrna profiling and genetics comparison with schizophrenia in a Malaysian population / Lim Chor Hong
Recent studies have shown that bipolar disorder (BPD) and schizophrenia (SZ) share some common genetic risk factors. This study aimed to examine the association between candidate single nucleotide polymorphisms (SNPs) identified from genomewide association studies (GWAS) and risk of BPD and SZ. A...
| Main Author: | |
|---|---|
| Format: | Thesis |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://studentsrepo.um.edu.my/7351/ http://studentsrepo.um.edu.my/7351/1/chor_hong.pdf |
| Summary: | Recent studies have shown that bipolar disorder (BPD) and schizophrenia (SZ) share
some common genetic risk factors. This study aimed to examine the association
between candidate single nucleotide polymorphisms (SNPs) identified from genomewide
association studies (GWAS) and risk of BPD and SZ. A total of 715 patients (244
BPD and 471 SZ) and 593 controls were genotyped using the Sequenom MassARRAY
platform. We showed a positive association between LMAN2L (rs6746896) and risk of
both BPD and SZ in a pooled population (P-value=0.001 and 0.009, respectively).
Following stratification by ethnicity, variants of the ANK3 gene (rs1938516 and
rs10994336) were found to be associated with BPD in Malays (P-value=0.001 and
0.006, respectively). Furthermore, an association exists between another variant of
LMAN2L (rs2271893) and SZ in the Malay and Indian ethnic groups (P-value=0.003
and 0.002, respectively). Gene-gene interaction analysis revealed a significant
interaction between the ANK3 and LMAN2L genes (empirical P=0.0107). Significant
differences were shown between patients and controls for two haplotype frequencies of
LMAN2L: GA (P=0.015 and P=0.010, for BPD and SZ, respectively) and GG (P=0.013
for BPD). Our study showed a significant association between LMAN2L and risk of
both BPD and SZ. Although major progress has been achieved in terms of research and
development, there stills exists gap in the knowledge of molecular mechanisms
underlying bipolar disorder (BPD) and action pathway of atypical antipsychotics.
MicroRNAs (miRNAs) are small non-coding RNA molecules that regulate gene
expression, including genes involved in neuronal function and plasticity. This study
aimed to examine the changes in miRNA expression in the blood of 14 bipolar mania
patients following 12 weeks of treatment with asenapine and risperidone using miRNA
microarray. A total of 24 miRNAs were differentially expressed after treatment in
asenapine group, 22 of which were significantly up-regulated and the other two were
iv
significantly down-regulated. However, all three differentially expressed miRNAs in the
risperidone group were down-regulated. MiRNA target gene prediction and gene
ontology analysis revealed significant enrichment for pathways associated with immune
system response and regulation of programmed cell death and transcription. Our results
show that miRNAs were involved in the pathway mechanism of both antipsychotics. |
|---|